Results 181 to 190 of about 23,258,662 (303)
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
A Narrative Review with Strategic Analysis of Home Care Services for Older Adults in Seoul, South Korea: Toward a Comprehensive Care Approach. [PDF]
Kim D +8 more
europepmc +1 more source
Intrinsic roles in the crosshair - strategic analysis of multi-site role implementation with an adapted matrix map approach. [PDF]
Griewatz J, Lammerding-Koeppel M.
europepmc +1 more source
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
Sustainable growth rate in the strategic analysis of brewery industry [PDF]
An analysis of sustainable growth rate could considerably improve an assessment of Strategic Business Unit’s potential. The sustainable growth rate analysis enabled us to compare a possible growth rate within the brewery industry with a growth rate that ...
Slonski, Tomasz +1 more
core
Strategic analysis of wind energy potential and optimal turbine selection in Al-Jouf, Saudi Arabia. [PDF]
Faraz MI.
europepmc +1 more source
Strategic Analysis of Shiraz Medical Tourism Industry: A Mixed Method Study. [PDF]
Rahimi Zarchi MK +5 more
europepmc +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source

